[Pharmacology of a new anti-angina preparation, nonachlazin].

Data on pharmacology of nonachlazine-a new antianginal preparation effective in the treatment of patients with ischemic heart disease-are presented. The drug tends to greatly improve the blood supply of the heart. Its beneficial action comes from the ability to intensively and protractedly enhance the coronary blood flow, thus increasing the oxygen reserve of the heart with the contractility of the myocardium rising without any substantial changes in the cardiac output and work.